SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Strides Pharma’s arm enters into agreement with Pii to acquire 18 ANDAs

07 Feb 2020 Evaluate

Strides Pharma Science’s step?down wholly?owned subsidiary -- Strides Pharma Global Pte has entered into a definitive asset transfer and licensing agreement with Pharmaceutics International, Inc.(Pii) to acquire 18 Abbreviated New Drug Application (ANDAs) for the US market.

With access to these products, the company will significantly expand its niche offerings on its front end, which has grown multi?folds to attain a quarterly revenue size of $66 million. Of the 18 products successfully developed by Pii with their Pharmaceutics Know How, 11 are currently approved by United States Food and Drug Administration (USFDA), while the remaining seven products are submitted and are under different stages of review with the Agency.

Out of the 11 approved ANDAs, the company is currently commercializing two ANDAs with product supply from Pii, while the remaining approved ANDAs will be transferred to Strides’ global manufacturing facilities and commercialized over the next 18?24 months. 

Strides Pharma Science (Formerly Strides Shasun) is a pharmaceutical company with a major focus on development and manufacture of IP-led niche finished dosage formulations. It is also among the world’s largest manufacturers of soft gelatin capsules.

Strides Pharma Scien Share Price

1115.75 36.15 (3.35%)
09-Jul-2026 11:01 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1930.40
Dr. Reddys Labs. 1289.70
Cipla 1442.35
Zydus Lifesciences 1167.10
Lupin 2504.30
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: